Pharvaris (PHVS) Income from Continuing Operations (2020 - 2026)

Pharvaris (PHVS) reported Income from Continuing Operations of 45574278.56 for Q1 2026, up 5.89% on a YoY basis from 43039096.55 in Q1 2025, and up 77.46% quarter-over-quarter from 202207598.07 in Q4 2025.

Pharvaris (PHVS) Income from Continuing Operations (2020 - 2026) Analysis & Trends

Pharvaris has reported Income from Continuing Operations for 7 years, with the latest figure at 45574278.56 in Q1 2026.

  • For the quarter ending Q1 2026, Income from Continuing Operations rose 5.89% year-over-year to 45574278.56; the trailing twelve-month figure through Mar 2026 stood at 342662025.82 (down 111.85% YoY), and the FY2025 full-year result was 198507144.79, down 36.64% from the prior year.
  • Income from Continuing Operations for Q1 2026 stood at 45574278.56, up from 202207598.07 in the prior quarter.
  • The five-year high for Income from Continuing Operations was 10542483.8 in Q2 2022, with the low at 202207598.07 in Q4 2025.
  • Historically, Income from Continuing Operations has averaged 42447790.13 across 5 years, with a median of 34430026.52 in 2023.
  • Annual changes were most pronounced in 2022 — Income from Continuing Operations jumped 42.41% — and 2025, when it plunged 464.49%.
  • Pharvaris' Income from Continuing Operations stood at 39680946.01 in 2022, then advanced by 13.23% to 34430026.52 in 2023, then fell by 4.04% to 35821184.65 in 2024, then sank by 464.49% to 202207598.07 in 2025, then jumped by 77.46% to 45574278.56 in 2026.
  • The last three Income from Continuing Operations figures came in at 45574278.56 (Q1 2026), 202207598.07 (Q4 2025), and 43627387.1 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - -26.94 Mn
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - -2.97 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn 30.80 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - -14.46 Mn
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -3.40 Mn
7 Psyence Biomedical 229.39 Bn 229.38 Bn - -1.50 Mn
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 1.03 Bn
9 Abivax 90.15 Bn 90.15 Bn - -56.48 Mn
10 Pharvaris 28.66 Bn 28.37 Bn - -45.57 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -45.57 Mn
Dec 31, 2025 -202.21 Mn
Sep 30, 2025 -43.63 Mn
Jun 30, 2025 -51.25 Mn
Mar 31, 2025 -48.43 Mn
Dec 31, 2024 -35.82 Mn
Sep 30, 2024 -45.55 Mn
Jun 30, 2024 -31.94 Mn
Mar 31, 2024 -30.13 Mn
Dec 31, 2023 -34.43 Mn
Sep 30, 2023 -25.53 Mn
Jun 30, 2023 -23.74 Mn
Mar 31, 2023 -24.23 Mn
Dec 31, 2022 -39.68 Mn
Sep 30, 2022 -10.98 Mn
Jun 30, 2022 -10.54 Mn
Mar 31, 2022 -17.94 Mn
Dec 31, 2021 -14.14 Mn
Sep 30, 2021 -10.70 Mn
Jun 30, 2021 -18.30 Mn